Melinda S. Epstein
- Cancer Research top 5%
- Breast Cancer Treatment Studies 11
- Oncology top 10%
- Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas 6
- Radiation top 10%
- Advanced Radiotherapy Techniques 4
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Hemophilia Treatment and Research 5
- Platelet Disorders and Treatments 4
-
- Lung Cancer Diagnosis and Treatment 3
-
- Cancer-related gene regulation 3
- Co-authors
- Melvin J. SilversteinMichael D. LagiosGottfried E. KonecnyH. HeppMalgorzata BerytY. Gloria MengMark D. PegramIngo Bauerfeind
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Melinda S. Epstein
20 papers receiving 624 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 327
- Oncology 300
- Pathology and Forensic Medicine 169
- Radiation 59
- Radiology, Nuclear Medicine and Imaging 120
Countries citing papers authored by Melinda S. Epstein
This map shows the geographic impact of Melinda S. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda S. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda S. Epstein more than expected).
Fields of papers citing papers by Melinda S. Epstein
This network shows the impact of papers produced by Melinda S. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda S. Epstein. The network helps show where Melinda S. Epstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Melinda S. Epstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 18 | |
| 2 | Intraoperative radiation therapy (IORT)for1200 early breast tumors | 2021 | 1 |
| 3 | 2021 | 1 | |
| 4 | 2018 | 26 | |
| 5 | 2017 | 20 | |
| 6 | 2016 | 21 | |
| 7 | 2016 | 22 | |
| 8 | 2016 | 9 | |
| 9 | 2015 | 9 | |
| 10 | 2015 | 39 | |
| 11 | 2014 | 1 | |
| 12 | 2013 | 18 | |
| 13 | 2013 | 11 | |
| 14 | 2012 | 2 | |
| 15 | 2011 | 1 | |
| 16 | 2006 | 55 | |
| 17 | 2005 | 77 | |
| 18 | 2004 | 230 | |
| 19 | 1997 | 23 | |
| 20 | 1992 | 56 |
About Melinda S. Epstein
Melinda S. Epstein is a scholar working on Cancer Research, Radiation and Hematology, having authored 20 papers that have together received 640 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (6 papers), Hemophilia Treatment and Research (5 papers), Platelet Disorders and Treatments (4 papers), Advanced Radiotherapy Techniques (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer-related gene regulation (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Cancer Research (327 citations), Oncology (300 citations) and Pathology and Forensic Medicine (169 citations). Melinda S. Epstein has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Melvin J. Silverstein, Michael D. Lagios, Gottfried E. Konecny, H. Hepp, Malgorzata Beryt, Y. Gloria Meng, Mark D. Pegram, Ingo Bauerfeind, Dennis J. Slamon and Hong Wang. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.